Absorb Bioresorbable Vascular Scaffolds vs. XIENCE Everolimus-Eluting Stents: Are Clinical Outcomes Different for Men and Women?

被引:0
|
作者
Kereiakes, Dean [1 ]
Ellis, Stephen [2 ]
Gao, Runlin [3 ]
Kimura, Takeshi [4 ]
Onuma, Yoshinobu [5 ]
Piard-Ruster, Karine [6 ]
Zhang, Yunlong [6 ]
Koo, Kai [6 ]
Serruys, Patrick [7 ]
Stone, Gregg [8 ]
机构
[1] Christ Hosp, Cincinnati, OH 45219 USA
[2] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] CAMS&PUMC, Fuwai Hosp, Beijing, Peoples R China
[4] Kyoto Univ Hosp, Kyoto, Japan
[5] Erasmus MC, Thoraxctr, Rotterdam, Netherlands
[6] Abbott Vasc, Santa Clara, CA USA
[7] Imperial Coll, London, England
[8] Columbia Univ, NewYork Presbyterian Hosp, Med Ctr, Cardiovasc Res Fdn, New York, NY USA
关键词
D O I
10.1016/j.jacc.2016.09.550
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-415
引用
收藏
页码:B168 / B168
页数:1
相关论文
共 50 条
  • [1] A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan
    Kimura, Takeshi
    Kozuma, Ken
    Tanabe, Kengo
    Nakamura, Sunao
    Yamane, Masahisa
    Muramatsu, Toshiya
    Saito, Shigeru
    Yajima, Junji
    Hagiwara, Nobuhisa
    Mitsudo, Kazuaki
    Popma, Jeffrey J.
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Ying, Shihwa
    Cao, Sherry
    Staehr, Peter
    Cheong, Wai-Fung
    Kusano, Hajime
    Stone, Gregg W.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (47) : 3332 - 3342
  • [2] Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents
    Sorrentino, Sabato
    Giustino, Gennaro
    Mehran, Roxana
    Kini, Anapoorna S.
    Sharma, Samin K.
    Faggioni, Michela
    Farhan, Serdar
    Vogel, Birgit
    Indolfi, Ciro
    Dangas, George D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (25) : 3055 - 3066
  • [3] Bioresorbable vascular scaffolds versus everolimus-eluting stents: a biomechanical analysis of the ABSORB III Imaging substudy
    Kumar, Arnav
    Gogas, Bill D.
    Thompson, Elizabeth W.
    Burnett, Grady Murphy
    Molony, David
    Hosseini, Hossein
    Chandran, Karthic
    Lefieux, Adrien
    Honda, Yasuhiro
    Lee, Joo Myung
    Serruys, Patrick W.
    Kereiakes, Dean J.
    Stone, Gregg W.
    Samady, Habib
    [J]. EUROINTERVENTION, 2020, 16 (12) : E989 - +
  • [4] ACUTE RECOIL FOLLOWING IMPLANTATION OF EVEROLIMUS-ELUTING ABSORB BIODEGRADABLE VASCULAR SCAFFOLDS OR XIENCE METALLIC STENTS: THE ABSORB II TRIAL
    Chevalier, Bernard
    Ishibashi, Yuki
    Onuma, Yoshinobu
    Serruys, Patrick W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1930 - A1930
  • [5] Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial
    Xu, Bo
    Yang, Yuejin
    Han, Yaling
    Huo, Yong
    Wang, Lefeng
    Qi, Xiangqian
    Li, Jifu
    Chen, Yundai
    Kuo, Hai-Chien
    Ying, Shih-Wa
    Cheong, Wai-Fung
    Zhang, Yunlong
    Su, Xiaolu
    Popma, Jeffery J.
    Gao, Runlin
    Stone, Gregg W.
    [J]. EUROINTERVENTION, 2018, 14 (05) : 554 - 561
  • [6] Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
    Onuma, Yoshinobu
    Chevalier, Bernard
    Ono, Masafumi
    Cequier, Angel
    Dudek, Dariusz
    Haude, Michael
    Carrie, Didier
    Sabate, Manel
    Windecker, Stephan
    Rapoza, Richard
    West, Nick E. J.
    Reith, Sebastian
    Almeida, Manuel de Sousa
    Campo, Gianluca
    Iniguez, Andres
    Serruys, Patrick W.
    [J]. EUROINTERVENTION, 2020, 16 (11) : E938 - E941
  • [7] Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds
    Puricel, Serban
    Arroyo, Diego
    Corpataux, Noe
    Baeriswyl, Gerard
    Lehmann, Sonja
    Kallinikou, Zacharenia
    Muller, Olivier
    Allard, Ludovic
    Stauffer, Jean-Christophe
    Togni, Mario
    Goy, Jean-Jacques
    Cook, Stephane
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (08) : 791 - 801
  • [8] 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds The ABSORB III Trial
    Kereiakes, Dean J.
    Ellis, Stephen G.
    Metzger, Christopher
    Caputo, Ronald P.
    Rizik, David G.
    Teirstein, Paul S.
    Litt, Marc R.
    Kini, Annapoorna
    Kabour, Ameer
    Marx, Steven O.
    Popma, Jeffrey J.
    McGreevy, Robert
    Zhang, Zhen
    Simonton, Charles
    Stone, Gregg W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (23) : 2852 - 2862
  • [10] Four-Year Clinical Outcomes From Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial
    Gao, Runlin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B128 - B128